You have 8 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Chemoradiation Therapy

Showing 26 - 50 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

High Grade Glioma Trial in Cleveland (procedure, radiation, drug)

Recruiting
  • High Grade Glioma
  • LITT
  • +2 more
  • Cleveland, Ohio
    Cleveland Clinic Taussig Cancer institute, Case Comprehensive Ca
Jan 5, 2023

HPV-Related Squamous Cell Carcinoma, Squamous Cell Carcinoma of the Oral Cavity, Squamous Cell Carcinoma of the Larynx Trial in

Not yet recruiting
  • HPV-Related Squamous Cell Carcinoma
  • +4 more
  • Cleveland, Ohio
    University Hospitals Cleveland Medical Center, Case Comprehensiv
Jan 31, 2023

Esophageal Squamous Cell Carcinoma, Tislelizumab, Chemoradiation Trial in Nanjing (Tislelizumab, Paclitaxel, Carboplatin)

Recruiting
  • Esophageal Squamous Cell Carcinoma
  • +2 more
  • Nanjing, Jiangsu, China
    Jiangsu Cancer Institute & Hospital
May 24, 2022

Esophagus Adenocarcinoma Trial in Frankfurt (Durvalumab, FLOT, mFOLFOX-6)

Not yet recruiting
  • Esophagus Adenocarcinoma
  • Frankfurt, Germany
    Institute of Clinical Cancer Research, University Cancer Center
Jan 26, 2023

Using Microbiome to Predict Durvalumab Toxicity in Post-

Recruiting
  • NSCLC, Stage III
  • Locally Advanced Lung Carcinoma
    • Kansas City, Kansas
    • +1 more
    May 17, 2022

    Muscle-Invasive Bladder Carcinoma, Programmed Cell Death Protein 1 Inhibitor, Radiotherapy Trial in Guangzhou (Toripalimab,

    Not yet recruiting
    • Muscle-Invasive Bladder Carcinoma
    • +2 more
    • Guangzhou, Guangdong, China
      Cancer Center, Sun Yat-sen University
    Aug 3, 2023

    Locally Advanced Rectal Cancer Trial in Beijing (Long-course chemoradiation, with Tislelizumab (PD-1 inhibitor), Long-course

    Recruiting
    • Locally Advanced Rectal Cancer
    • Long-course chemoradiation, with Tislelizumab (PD-1 inhibitor)
    • Long-course chemoradiation, without Tislelizumab (PD-1 inhibitor)
    • Beijing, Beijing, China
      Beijing Friendship Hospital, Capital Medical University
    Apr 25, 2023

    Uterine Cervical Tumors Trial in Toronto (Hyperpolarized 13C-Pyruvate, 18F-FDG)

    Terminated
    • Uterine Cervical Neoplasms
    • Toronto, Ontario, Canada
      Sunnybrook Health Sciences Centre
    Sep 20, 2022

    Pancreatic Cancer Trial (Chemotherapy, Radiation)

    Active, not recruiting
    • Pancreatic Cancer
    • (no location specified)
    May 30, 2022

    Esophageal Adenocarcinoma Trial in Buffalo (Carboplatin, 3 Dimensional Conformal Radiation Therapy, Propranolol)

    Recruiting
    • Esophageal Adenocarcinoma
    • Buffalo, New York
      Roswell Park Cancer Institute
    Aug 3, 2022

    Head Neck Cancer Trial in United States (geriatric co-management, geriatric guided supportive care)

    Recruiting
    • Head and Neck Cancer
    • geriatric co-management
    • geriatric guided supportive care
    • Basking Ridge, New Jersey
    • +5 more
    Dec 21, 2022

    NSCLC Trial in Shanghai (Tislelizumab, Sitravatinib)

    Recruiting
    • Non-small Cell Lung Cancer
    • Shanghai, China
      Fudan University Shanghai Cancer Center
    Dec 15, 2021

    Breast Cancer, Breast Cancer Stage I, Breast Cancer Stage II Trial in Charlottesville (T-DM1, Capecitabine, External Beam

    Not yet recruiting
    • Breast Cancer
    • +3 more
    • Charlottesville, Virginia
      University of Virginia
    Apr 12, 2022

    Glioblastoma, Surgery, High Grade Glioma Trial in Danville, Wilkes-Barre (radiation, drug, procedure)

    Recruiting
    • Glioblastoma
    • +2 more
    • Neoadjuvant chemoradiation
    • +2 more
    • Danville, Pennsylvania
    • +1 more
    Jan 24, 2022

    Rectal Cancer Trial in Alexandria (radiation, drug, procedure)

    Completed
    • Rectal Cancer
    • Radiotherapy
    • +2 more
    • Alexandria, Egypt
      Ahmed Samir Ashoor
    Mar 7, 2022

    Nasopharyngeal Cancer Trial in Shanghai (Toripalimab, Induction chemo and concurrent chemoradiation)

    Recruiting
    • Nasopharyngeal Cancer
    • Toripalimab
    • Induction chemotherapy and concurrent chemoradiation
    • Shanghai, Shanghai, China
      Fudan Universtiy Shanghai Cancer Centre
    Nov 25, 2022

    Gastric Adenocarcinoma, Oligometastasis, Stage IV Esophageal Adenocarcinoma AJCC v7 Trial in Houston (drug, procedure,

    Recruiting
    • Gastric Adenocarcinoma
    • +4 more
    • Houston, Texas
      M D Anderson Cancer Center
    Sep 20, 2022

    Glioblastoma, Adult Trial in United States (Paxalisib (GDC-0084))

    Active, not recruiting
    • Glioblastoma, Adult
    • Paxalisib (GDC-0084)
    • Los Angeles, California
    • +5 more
    Aug 16, 2022

    Glioblastoma, Astrocytoma, Grade III, Astrocytoma, Grade IV Trial in Lake Success (Stereotactic Radiosurgery)

    Active, not recruiting
    • Glioblastoma
    • +3 more
    • Stereotactic Radiosurgery
    • Lake Success, New York
      Northwell Health Brain Tumor Center
    Feb 3, 2022

    Stage III Cutaneous Squamous Cell Carcinoma of the Head and Neck AJCC v8, Stage IV Cutaneous Squamous Cell Carcinoma of the Head

    Completed
    • Stage III Cutaneous Squamous Cell Carcinoma of the Head and Neck AJCC v8
    • Stage IV Cutaneous Squamous Cell Carcinoma of the Head and Neck AJCC v8
    • Buffalo, New York
      Roswell Park Cancer Institute
    Dec 8, 2021

    HPV Positive Oropharyngeal Squamous Cell Carcinoma Trial in United States (Cisplatin-based Radiation Therapy, Cisplatin

    Recruiting
    • HPV Positive Oropharyngeal Squamous Cell Carcinoma
    • Cisplatin-based Radiation Therapy
    • Cisplatin Chemotherapy
    • Beverly Hills, California
    • +3 more
    Jul 6, 2022

    Concurrent Paclitaxel and Radiotherapy After Adjuvant

    Not yet recruiting
    • Breast Cancer
    • Concurrent chemoradiation
    • (no location specified)
    Oct 16, 2022

    Esophageal Carcinoma Trial in Rochester (mFOLFOX6, Chemoradiation)

    Active, not recruiting
    • Esophageal Carcinoma
    • Rochester, New York
      University of Rochester
    Aug 17, 2022

    Locally Advanced Rectal Cancer Trial (Radiation therapy, chemo and immune checkpoint inhibitor)

    Not yet recruiting
    • Locally Advanced Rectal Cancer
    • Radiation therapy, chemotherapy and immune checkpoint inhibitor
    • (no location specified)
    Mar 28, 2022

    Pancreas Adenocarcinoma Trial in Detroit, Milwaukee (CPI-613® (Dose level -1.0 250 mg/m^2), CPI-613® (Dose level 1.0 500

    Recruiting
    • Pancreas Adenocarcinoma
    • CPI-613® (Dose level -1.0 250 mg/m^2)
    • +6 more
    • Detroit, Michigan
    • +1 more
    Nov 9, 2022